Paediatric Atypical Antipsychotic Monitoring Safety (PAMS) Study: Pilot Study in Children and Adolescents in Secondary- and Tertiary-Care Settings

By Rani Fariz A.   Byrne Patrick J.   Murray Macey L.   Carter Paul   Wong Ian C.K.  

Drug Safety, Vol. 32, Iss. 4, 2009-01 ,pp. : 325-333

Adis International

Access to resources Recommend Favorite

Predictors of mortality in atypical antipsychotic-treated community-dwelling elderly patients with behavioural and psychological symptoms of dementia: a prospective population-based cohort study from Italy

By Rafaniello Concetta   Lombardo Flavia   Ferrajolo Carmen   Sportiello Liberata   Parretta Elisabetta   Formica Ranieri   Potenza Simona   Rinaldi Barbara   Irpino Antonio   Raschetti Roberto   Vanacore Nicola   Rossi Francesco   Capuano Annalisa  

European Journal of Clinical Pharmacology, Vol. 70, Iss. 2, 2014-02 ,pp. : 187-195

Springer Publishing Company

Access to resources Recommend Favorite

Safety of medicines in children

By Bush Andrew  

Expert Opinion on Drug Safety, Vol. 2, Iss. 2, 2003-03 ,pp. : 109-112

Informa Healthcare

Access to resources Recommend Favorite

Differential Effects of Atypical versus Typical Antipsychotic Medication on Earnings of Schizophrenia Patients: Estimates from a Prospective Naturalistic Study

By Salkever David  

PharmacoEconomics, Vol. 24, Iss. 2, 2006-01 ,pp. : 123-139

Adis International

Access to resources Recommend Favorite

Mortality in Children and Adolescents Prescribed Antipsychotic Medication: A Retrospective Cohort Study Using the UK General Practice Research Database

By Rani Fariz A.   Byrne Patrick  

Drug Safety, Vol. 34, Iss. 9, 2011-09 ,pp. : 773-781

Adis International

Access to resources Recommend Favorite